Related Experiment Video
Updated: May 28, 2025

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
Published on: May 8, 2017
Dual-Locked Near-Infrared Fluorescent Probe for Real-Time Imaging of Hydrogen Sulfide/Matrix Metallopeptidase-2 In
Luyan Wu1, Qiang Tong1, Xiang Cao2
1State Key Laboratory of Flexible Electronics (LoFE), Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), School of Materials Science and Engineering, Nanjing University of Posts and Telecommunications, Nanjing 210023, China.
Abstract:
Hydrogen sulfide (H2S) and matrix metallopeptidase 2 (MMP-2) are inextricably linked in the occurrence and development of diseases and the treatment of diseases. However, most of the activatable imaging probes currently developed are single-locked probes that do not simultaneously detect H2S and MMP-2 levels at disease sites and severely hinder the real-time and accurate analysis of the dynamic relationship between the two interrelated biomarkers. Herein, we report a dual-locked H2S/MMP-2-activatable near-infrared (NIR) fluorescent imaging probe through a dual-Förster resonance energy transfer (FRET) mechanism that specifically detects tumors or acute lung injury (ALI) and establishes the dynamic relationship between the H2S level and MMP-2 expression. Initially, the fluorescence of the probe is turned off due to energy transfer from methylene blue (MB) to both the cationic electrochromic material (dicationic 1,1,4,4-tetraarylbutadiene, EM 12+) and quencher QSY21. Upon reaction with H2S/MMP-2 in tumors or ALI, the NIR fluorescence of the probe is activated, enabling accurate real-time imaging of tumors or ALI. Additionally, this probe precisely tracks the effects of exogenous H2S in tumors or glucocorticoids for the treatment of ALI on MMP-2 expression, providing a powerful molecular imaging tool for early prediction of treatment outcomes in tumors and ALI.

